e-learning
resources
Munich 2006
Sunday 03.09.2006
Epidemiology and treatment of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Anti tuberculosis drug induced hepatitis in Sri Lankan patients
W. V. Senaratne, M. J. Pinidiyapathirage, E. Perera, A. R. Wickremasinghe (Welisara, Ragama, Sri Lanka)
Source:
Annual Congress 2006 - Epidemiology and treatment of tuberculosis
Session:
Epidemiology and treatment of tuberculosis
Session type:
Electronic Poster Discussion
Number:
1743
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. V. Senaratne, M. J. Pinidiyapathirage, E. Perera, A. R. Wickremasinghe (Welisara, Ragama, Sri Lanka). Anti tuberculosis drug induced hepatitis in Sri Lankan patients. Eur Respir J 2006; 28: Suppl. 50, 1743
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
An analysis of mortality among patients with tuberculosis (TB) in Sri Lanka
Source: Annual Congress 2011 - Tuberculosis epidemiology and public health
Year: 2011
High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
HIV seroprevalence among tuberculosis patients in Tripoli Libya
Source: Eur Respir J 2004; 24: Suppl. 48, 197s
Year: 2004
A study on prevalence of latent tuberculosis in prison inmates of a single outdoor prison in central Sri Lanka
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020
Prevalence of latent tuberculosis among refugee children in Malaysia
Source: ERJ Open Res, 6 (1) 00254-2019; 10.1183/23120541.00254-2019
Year: 2020
Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicity
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Influence of viral hepatitis and anti-TB drugs on hepatocyte disfunction in patients with MDR/XDR tuberculosis
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021
Treatment of latent tuberculosis in immigrants from Somalia: Case-monitoring and adherence
Source: Annual Congress 2010 - Tuberculosis in special populations
Year: 2010
Risk factors of drug -induced hepatitis among patients with TB/HIV co-infection
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010
Impact of HIV infection on drug resistance pattern of anti-tuberculosis drugs in PTB cases in Eastern Uttar Pradesh (India)
Source: Eur Respir J 2004; 24: Suppl. 48, 438s
Year: 2004
Clinico-radiological profile of tuberculosis in HIV seropositive patients of western Rajasthan
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Year: 2008
Particularities of tuberculosis at children hospitalized with HIV co-infection
Source: Annual Congress 2009 - Tuberculosis at different age groups
Year: 2009
Safety of bedaquiline for treatment of MDR/XDR tuberculosis in HIV co-infected patients
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Should patients with active tuberculosis be routinely screened for chronic viral hepatitis?
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Anti tubercular chemoprophylaxis regimens in HIV seropositives with latent tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 566s
Year: 2002
Tuberculosis for HIV infected patients in Latvia
Source: Eur Respir J 2001; 18: Suppl. 33, 314s
Year: 2001
HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
Prevalence of urban vs rural HIV infection in patients of pulmonary tuberculosis: An Indian scenario
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010
Multidrug-resistance tuberculosis and HIV-infected patients, the effectiveness of the treatment in Ukraine
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Recurrent tuberculosis among HIV infected persons in Singapore
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept